Reply

American Journal of Ophthalmology

Volumn 160, Issue 4, 2015, Pages 844-

  Dossarps, Denis ^a   Bron, Alain M ^a   Koehrer, Philippe ^a   Aho Glélé, Ludwig S ^a   Creuzot Garcher, Catherine ^a  

^a NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

BOSNIA AND HERZEGOVINA; DILUTION; DRUG CONTAMINATION; ENDOPHTHALMITIS; HUMAN; INFECTION RATE; LETTER; OFF LABEL DRUG USE; OPHTHALMOLOGIST; PRIORITY JOURNAL; RESIDENCY EDUCATION; RESIDENT; ADVERSE EFFECTS; EYE INFECTIONS, BACTERIAL; FEMALE; INTRAVITREAL DRUG ADMINISTRATION; MALE; PHYSIOLOGY; VISUAL ACUITY;

ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; VISUAL ACUITY;

EID: 84941425617     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2015.07.002     Document Type: Letter

References (2)

1. D. Dossarps, A.M. Bron, P. Koehrer, L.S. Aho-Glele, C. Creuzot-Garcher for the FRCR NET (FRENCH RETINA SPECIALISTS NET) Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome Am J Ophthalmol 160 1 2015 17 25
2. K.G. Falavarjani, M. Aghamirsalim, M. Modarres, and et al. Endophthalmitis after resident-performed intravitreal bevacizumab injection Can J Ophthalmol 50 1 2015 33 36